Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19

Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19

Abstract In the current global emergency due to SARS-CoV-2 outbreak, passive immunotherapy emerges as a promising treatment for COVID-19. Among animal-derived products, equine formulations are still the cornerstone therapy for treating envenomations due to animal bites and stings. Therefore, drawing...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Guillermo León, María Herrera, Mariángela Vargas, Mauricio Arguedas, Andrés Sánchez, Álvaro Segura, Aarón Gómez, Gabriela Solano, Eugenia Corrales-Aguilar, Kenneth Risner, Aarthi Narayanan, Charles Bailey, Mauren Villalta, Andrés Hernández, Adriana Sánchez, Daniel Cordero, Daniela Solano, Gina Durán, Eduardo Segura, Maykel Cerdas, Deibid Umaña, Edwin Moscoso, Ricardo Estrada, Jairo Gutiérrez, Marcos Méndez, Ana Cecilia Castillo, Laura Sánchez, Ronald Sánchez, José María Gutiérrez, Cecilia Díaz, Alberto Alape
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/027fa4cb9478458880985f67c1848752
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/027fa4cb9478458880985f67c1848752

Ejemplares similares